NeurologyOnline.net

Neurology Xagena

Search results for "Dopamine agonists"

Levodopa is standard, and often initial, therapy for patients with Parkinson's disease; however, with continued treatment and as the disease progresses, up to 80% of patients experience wearing-off sy ...


A review of studies has concluded that, compared to older drugs for Parkinson disease, a newer class of medications called dopamine agonists might be better at preventing some of the disabling muscl ...


Parkinson disease is a slowly progressive neurodegenerative disorder. Early Parkinson disease, or stage 1 or 2 on the Unified Parkinson’s Disease Rating Scale ( UPDRS ), is characterized by mild sympt ...


The results from phase III studies with Safinamide were presented at at the 9th International Congress on Mental Dysfunction & Other Non-Motor Features in Parkinson’s Disease and Related Disorders ...


Dopamine agonists are used as initial symptomatic therapy for early Parkinson’s disease, escalating dose or addition of Levodopa needed over time to maintain symptom control. Increasing dopamine ago ...


Dopamine agonists are often used as first-line monotherapy for the symptomatic control of Parkinson's disease. However, dopamine agonist monotherapy typically becomes inadequate within a few years, at ...


Up to 70% of Parkinson’s disease ( PD ) patients experience sleep problems that negatively impact their quality of life. Some patients have disturbed sleep/wake patterns such as difficulty falling asl ...


The Committee for Medicinal Products for Human Use ( CHMP ) has recommended that the European Commission approve the use of Xadago ( Safinamide ) as add-on to L-dopa alone or in combination with dopam ...


Whether initial treatment for Parkinson's disease should consist of Levodopa, dopamine agonists, or monoamine oxidase type B inhibitors ( MAOBI ) is uncertain. Researchers aimed to establish which o ...


A 7-year experience assessing safety and outcomes of Levodopa / Carbidopa intestinal gel infusion ( LCIG ) in 59 advanced Parkinson disease ( PD ) patients presenting motor fluctuations and severe dys ...